Susquehanna International Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.66M | Buy |
|
|||||
|
2025
Q1 | $2.64M | Buy |
|
|||||
|
2024
Q4 | $893K | Buy |
|
|||||
|
2024
Q3 | $468K | Sell |
|
|||||
|
2024
Q2 | $509K | Sell |
|
|||||
|
2024
Q1 | $993K | Sell |
|
|||||
|
2023
Q4 | $1.06M | Buy |
|
|||||
|
2023
Q3 | $203K | Buy |
|
|||||
|
2023
Q2 | $142K | Sell |
|
|||||
|
2023
Q1 | $1.17M | Buy |
|
|||||
|
2022
Q4 | $330K | Sell |
|
|||||
|
2022
Q3 | $1.16M | Buy |
|
|||||
|
2022
Q2 | $739K | Buy |
|
|||||
|
2022
Q1 | $374K | Sell |
|
|||||
|
2021
Q4 | $464K | Sell |
|
|||||
|
2021
Q3 | $562K | Buy |
|
|||||
|
2021
Q2 | $507K | Sell |
|
|||||
|
2021
Q1 | $1.01M | Buy |
|
|||||
|
2020
Q4 | $314K | Sell |
|
|||||
|
2020
Q3 | $990K | Buy |
|
|||||
|
2020
Q2 | $351K | Buy |
|